Skin checks for potential skin cancers in general practice in Victoria, Australia: the upfront and downstream patterns and costs
David E Goldsbury A * , Damien McCarthy B , Caroline G Watts A C , Chi So D , Olivia Wawryk B , Chris Kearney B , Gillian Reyes-Marcelino A B , Kirstie McLoughlin A , Jon Emery B F and Anne E Cust A DA
B
C
D
E
F
Abstract
To describe patterns of skin checks for potential skin cancers in general practice and subsequent skin-related healthcare, and the associated costs.
Retrospective longitudinal health record linkage.
Patient encounters between 2010 and 2017 were extracted from clinical information systems at 73 general practice sites in Victoria, Australia, including Medicare billing information, from the MedicineInsight primary care dataset. The main outcomes were skin checks, skin-related healthcare up to 3 months after the skin check, and health system costs.
There were 59 046 skin check encounters (0.7% of all general practice encounters) identified for 40 014 people with a median age of 52 years (interquartile range 36–67). Of these people, 26% had multiple skin checks. Of the subsequent skin checks, 28% were within 3 months of the initial skin check and 15% were after > 2 years. There was subsequent skin-related healthcare ≤ 3 months after 20% of all skin checks: 8% had a skin biopsy, 11% had a skin excision (of which 2% indicated a melanoma diagnosis, 29% keratinocyte carcinoma and 68% benign or other skin lesion), 2% had skin-related medicine prescribed and 5% had other skin-related treatment such as cryotherapy (not mutually exclusive). Ninety per cent of skin checks were billed as general practitioner (GP) consultations, including 65% as GP consultations of < 20 minutes although the proportion of longer consultations increased over time. The mean 3-month skin-related general practice health system costs for people without and with subsequent skin-related healthcare were A$58 and A$240, respectively, and up to a mean of A$595 for those having a melanoma excised.
Skin checks for potential skin cancers occur frequently in Australian general practice and accumulate substantial health system costs, with one in five skin checks resulting in subsequent treatment. This study adds to scarce real-world skin check and cost data in Australia.
References
1 Australian Institute of Health and Welfare Skin cancer in Australia. Canberra, ACT: AIHW; 2016 [cited 2024 Apr 23]. Available from: www.aihw.gov.au/getmedia/0368fb8b-10ef-4631-aa14-cb6d55043e4b/18197.pdf?v=20230605165347&inline=true
2 Watts CG, Madronio CM, Morton RL, Goumas C, Armstrong BK, Curtin A, et al. Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: a population-based study in New South Wales, Australia. Australas J Dermatol 2017; 58(4): 278-285.
| Crossref | Google Scholar |
3 American Society of Clinical Oncology. Skin cancer (non-melanoma): Introduction. VA, US: ASCO; 2022 [cited 2022 Nov 7]. Available from: www.cancer.net/cancer-types/skin-cancer-non-melanoma/introduction
4 Cancer Council Australia. Keratinocyte Cancers Guideline Working Party. Clinical practice guidelines for keratinocyte cancer. Sydney: Cancer Council Australia; 2019 [cited 2023 Feb 6]. Available from: wiki.cancer.org.au/australia/Guidelines:Keratinocyte_carcinoma
5 Cancer Council Australia. Melanoma Guidelines Working Party. Clinical practice guidelines for the diagnosis and management of melanoma. Sydney, NSW: Melanoma Institute Australia; 2020 [cited 2023 Feb 6]. Available from: www.cancer.org.au/clinical-guidelines/skin-cancer/melanoma
6 Australian Institute of Health and Welfare. Health expenditure. Canberra, ACT: AIHW;, 2023 [cited 2023 Dec 5]. Available from: www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure
7 Department of Health and Aged Care. Medicare Benefits Schedule (MBS) online. Canberra, ACT: Australian Government; 2022 [cited 2022 Oct 11]. Available from: www.mbsonline.gov.au
8 Department of Health and Aged Care. Pharmaceutical Benefits Scheme (PBS). Canberra, ACT: Australian Government; 2022 [cited 2022 Oct 11]. Available from: www.pbs.gov.au/pbs/home
9 Janda M, Cust AE, Neale RE, Aitken JF, Baade PD, Green AC, et al. Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre melanoma screening summit. Aust N Z J Public Health 2020; 44(2): 111-15.
| Crossref | Google Scholar |
10 Australian Commission on Safety and Quality in Health Care. NPS MedicineInsight [cited 2024 May 1]. Canberra, ACT: ACSQHC; 2024. Available from: https://www.safetyandquality.gov.au/our-work/indicators-measurement-and-reporting/medicineinsight
11 Busingye D, Gianacas C, Pollack A, Chidwick K, Merrifield A, Norman S, et al. Data Resource Profile: MedicineInsight, an Australian national primary health care database. Int J Epidemiol 2019; 48(6): 1741-1741h.
| Crossref | Google Scholar |
12 BioGrid Australia. Melbourne, Victoria; BioGrid Australia; 2022 [cited 2022 Feb 22]. Available from: www.biogrid.org.au
13 Australian Bureau of Statistics. Census of population and housing: Socio-Economic Indexes for Areas (SEIFA), Australia 2016. Canberra, ACT: ABS; 2016 [cited 2022 Oct 11]. Available from: www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/2033.0.55.0012016?OpenDocument
14 Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 5 – Remoteness Structure, July 2016. Canberra, ACT: ABS; 2016 [cited 2022 Oct 11]. Available from: www.abs.gov.au/ausstats/abs@.nsf/mf/1270.0.55.005
15 Australian Bureau of Statistics. Consumer price index Australia: June 2020. Canberra, Australia; AIHW; 2020 [cited 2024 Apr 23]. Available from: www.abs.gov.au/statistics/economy/price-indexes-and-inflation/consumer-price-index-australia/jun-2020
16 Gordon LG, Leung W, Johns R, McNoe B, Lindsay D, Merollini KMD, et al. Estimated healthcare costs of melanoma and keratinocyte skin cancers in Australia and Aotearoa New Zealand in 2021. Int J Environ Res Public Health. 2022; 19: 3178.
| Crossref | Google Scholar |
17 Thompson BS, Olsen CM, Subramaniam P, Neale RE, Whiteman DC.. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study. Aust N Z J Public Health. 2016; 40(2): 154-8.
| Crossref | Google Scholar |
18 Services Australia. Medicare item reports. Canberra, ACT: Australian Government; 2023 [cited 2023 Jan 18]. Available from: http://medicarestatistics.humanservices.gov.au/statistics/mbs_item.jsp
19 Reyes-Marcelino G, McLoughlin K, Harrison C, Watts CG, Kang YJ, Aranda S, et al. Skin cancer-related conditions managed in general practice in Australia, 2000-2016: a nationally representative, cross-sectional survey. BMJ Open. 2023; 13: e067744.
| Crossref | Google Scholar |
20 Reyes-Marcelino G, Tabbakh T, Espinoza D, Sinclair C, Kang YJ, McLoughlin K, et al. Prevalence of skin examination behaviours among Australians over time. Cancer Epidemiol. 2021; 70: 101874.
| Crossref | Google Scholar |
21 Australian Institute of Health and Welfare. Cancer data in Australia. Canberra, ACT: AIHW; 2023 [cited 2023 Dec 12]. Available from: www.aihw.gov.au/reports/cancer/cancer-data-in-australia
22 Busingye D, Myton R, Mina R, Thistlethwaite J, Belcher J, Chidwick K. MedicineInsight report: Validation of the MedicineInsight database: completeness, generalisability and plausibility. Sydney: NPS MedicineWise; 2020 [cited 2024 Apr 23]. Available from: policycommons.net/artifacts/4334389/medicineinsight-validation-of-the-medicineinsight-database/5142995
23 NPS MedicineWise. General Practice Insights Report July 2017 – June 2018. Sydney: NPS MedicineWise; 2019. Sydney: NPS Medicinewise; 2018 [cited 2024 Apr 23]. Available from: www.nps.org.au/assets/NPS/pdf/General-Practice-Insights-Report_2017-18.pdf
24 Department of Health and Aged Care. Medicare statistics collection – Per patient bulk billing dashboard 2021–22. Canberra, ACT: Australian Government; 2022 [cited 2023 Apr 17]. Available from: www.health.gov.au/resources/collections/medicare-statistics-collection